Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijbiomac.2023.125782 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "aptamer/doxorubicin-conjugated
4
"aptamer/doxorubicin-conjugated nanoparticles
4
nanoparticles target
4
target membranous
4
membranous cemip2
4
cemip2 colorectal
4
colorectal cancer"
4
cancer" [int
4
[int macromol
4
macromol 245
4
Similar Publications
Retraction notice to "Corrigendum to 'Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer' [International Journal of Biological Macromolecules 248 (2023) 125782]".
Int J Biol Macromol
January 2025
Institute of Biomedical Sciences, College of Medicine, National Sun Yat-sen University, Kaohsiung 80424, Taiwan; Department of Mechanical and Electro-Mechanical Engineering, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Corrigendum to: "Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer" [Int. J. Biol Macromol. 245 (2023) Jun 21; 125510/Online ahead of print. PMID: 37353120; IJBIOMAC-D-23-03903R1].
Int J Biol Macromol
September 2023
Institute of Biomedical Sciences, College of Medicine, National Sun Yat-sen University, Kaohsiung 80424, Taiwan; Department of Mechanical and Electro-Mechanical Engineering, National Sun Yat-sen University, Kaohsiung 80424, Taiwan. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!